Veryan Medical

Executive Summary

Veryan Medical is a private Irish medical device company specializing in innovative cardiovascular stents. Its flagship product, the BioMimics 3D Vascular Stent System, features a unique helical geometry that imparts a gentle helical shape to the stented artery, potentially reducing restenosis and improving clinical outcomes. The company has generated strong clinical evidence through the MIMICS clinical program, demonstrating safety and efficacy in treating peripheral artery disease. Founded in 2005 and based in Galway, Veryan has established a foothold in European markets with CE marking and is now pursuing US regulatory approval to expand its addressable market. The company's proprietary technology differentiates it from conventional straight stents, addressing a significant unmet need in vascular intervention. As a private entity, Veryan continues to invest in clinical trials and commercialization, aiming to capture share in the multi-billion-dollar peripheral stent market. Its success hinges on regulatory milestones, clinical data publication, and strategic partnerships.

Upcoming Catalysts (preview)

• Q3 2026FDA Approval Decision for BioMimics 3D60% success
• Q4 2026Publication of 2-Year MIMICS Clinical Trial Results80% success
• Q2 2026EU Distribution Partnership for Market Expansion50% success